San Diego, CA -- (SBWire) -- 03/22/2022 --Certain directors of Natera, Inc are under investigation over potential breaches of fiduciary duties.
Investors who purchased shares of Natera, Inc. (NASDAQ: NTRA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Natera, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
San Carlos, CA based Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. On January 1, 2022, an article from the New York Times called into question the accuracy of certain prenatal tests, alleging that positive results on tests are incorrect about 85 percent of the time, and that patients who receive a positive result are supposed to pursue follow-up testing, which "can cost thousands of dollars, come with a small risk of miscarriage and can't be performed until later in pregnancy."
Those who purchased shares of Natera, Inc. (NASDAQ: NTRA) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
NASDAQ:NTRA Shareholder Notice: Investigation over Potential Wrongdoing at Natera, Inc.
An investigation on behalf of investors in Natera, Inc. (NASDAQ:NTRA) shares over potential wrongdoing at Natera, Inc. was announced.